Details for Patent: 12,559,474
✉ Email this page to a colleague
Which drugs does patent 12,559,474 protect, and when does it expire?
Patent 12,559,474 protects XOCOVA and is included in one NDA.
This patent has forty-one patent family members in twenty-six countries.
Summary for Patent: 12,559,474
| Title: | Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same |
| Abstract: | A compound represented by Formula (I): wherein Y is N or the like; R1 is substituted or unsubstituted aromatic heterocyclyl or the like; R2 is substituted or unsubstituted aromatic carbocyclyl or the like; R3 is substituted or unsubstituted aromatic heterocyclyl or the like; —X— is —NH— or the like; m is 1 or the like; R5a is each independently a hydrogen atom or the like; R5b is each independently a hydrogen atom or the like; n is 1 or the like; R4a is each independently a hydrogen atom or the like; and R4b is each independently a hydrogen atom or the like, or a pharmaceutically acceptable salt thereof. |
| Inventor(s): | Yuki Tachibana, Shota UEHARA, Yuto Unoh, Kenji Nakahara, Yoshiyuki Taoda, Koji KASAMATSU, Yukiko YAMATSU, Shigeru Ando, Takahiro SUTO, Michihito SASAKI |
| Assignee: | Hokkaido University NUC , Shionogi and Co Ltd |
| Application Number: | US17/790,358 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 12,559,474
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shionogi | XOCOVA | ensitrelvir | TABLET;ORAL | 220442-001 | May 29, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | POST-EXPOSURE PROPHYLAXIS OF CORONAVIRUS DISEASE 2019 (COVID 19) IN ADULTS AND ADOLESCENTS 12 YEARS OF AGE AND OLDER | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,559,474
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2022204775 | ⤷ Start Trial | |||
| Brazil | 122023002208 | ⤷ Start Trial | |||
| Canada | 3195272 | ⤷ Start Trial | |||
| Chile | 2023003041 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
